330 related articles for article (PubMed ID: 18661488)
1. Combined test + inhibin A at week 13 in contingent sequential testing: an interesting alternative for first-trimester prenatal screening for Down syndrome.
Ramos-Corpas DJ; Santiago JC
Prenat Diagn; 2008 Sep; 28(9):833-8. PubMed ID: 18661488
[TBL] [Abstract][Full Text] [Related]
2. First-trimester or second-trimester screening, or both, for Down's syndrome.
Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
[TBL] [Abstract][Full Text] [Related]
3. Comparison of serum markers in first-trimester down syndrome screening.
Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
[TBL] [Abstract][Full Text] [Related]
4. Comparison of first-trimester contingent screening strategies for Down syndrome.
Sahota DS; Leung TY; Chan LW; Law LW; Fung TY; Chen M; Lau TK
Ultrasound Obstet Gynecol; 2010 Mar; 35(3):286-91. PubMed ID: 20052660
[TBL] [Abstract][Full Text] [Related]
5. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A
Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
[TBL] [Abstract][Full Text] [Related]
6. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening.
Wright D; Bradbury I; Benn P; Cuckle H; Ritchie K
Prenat Diagn; 2004 Oct; 24(10):762-6. PubMed ID: 15503281
[TBL] [Abstract][Full Text] [Related]
7. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.
Christiansen M; Nørgaard-Pedersen B
Clin Genet; 2005 Jul; 68(1):35-9. PubMed ID: 15952984
[TBL] [Abstract][Full Text] [Related]
8. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
9. Contingent screening for Down syndrome--results from the FaSTER trial.
Cuckle HS; Malone FD; Wright D; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Ferreira JC; Dugoff L; Craigo SD; Timor IE; Carr SR; Wolfe HM; D'Alton ME
Prenat Diagn; 2008 Feb; 28(2):89-94. PubMed ID: 18236423
[TBL] [Abstract][Full Text] [Related]
10. First- and second-trimester evaluation of risk for Down syndrome.
Ball RH; Caughey AB; Malone FD; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Emig D; D'Alton ME;
Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
[TBL] [Abstract][Full Text] [Related]
11. Integrated serum screening for Down syndrome in primary obstetric practice.
Knight GJ; Palomaki GE; Neveux LM; Smith DE; Kloza EM; Pulkkinen AJ; Williams J; Haddow JE
Prenat Diagn; 2005 Dec; 25(12):1162-7. PubMed ID: 16231402
[TBL] [Abstract][Full Text] [Related]
12. Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy.
Wald NJ; Barnes IM; Birger R; Huttly W
Prenat Diagn; 2006 Jun; 26(6):539-44. PubMed ID: 16634123
[TBL] [Abstract][Full Text] [Related]
13. Three-stage contingent screening for Down syndrome.
Wright D; Bradbury I; Cuckle H; Gardosi J; Tonks A; Standing S; Benn P
Prenat Diagn; 2006 Jun; 26(6):528-34. PubMed ID: 16634118
[TBL] [Abstract][Full Text] [Related]
14. Comparison of combined, stepwise sequential, contingent, and integrated screening in 7292 high-risk pregnant women.
Guanciali-Franchi P; Iezzi I; Palka C; Matarrelli B; Morizio E; Calabrese G; Benn P
Prenat Diagn; 2011 Nov; 31(11):1077-81. PubMed ID: 21800336
[TBL] [Abstract][Full Text] [Related]
15. Sequential and contingent prenatal screening for Down syndrome.
Wald NJ; Rudnicka AR; Bestwick JP
Prenat Diagn; 2006 Sep; 26(9):769-77. PubMed ID: 16821246
[TBL] [Abstract][Full Text] [Related]
16. Cross-trimester marker ratios in prenatal screening for Down syndrome.
Wald NJ; Bestwick JP; Morris JK
Prenat Diagn; 2006 Jun; 26(6):514-23. PubMed ID: 16739232
[TBL] [Abstract][Full Text] [Related]
17. Repeated measures screening for Down's Syndrome.
Wright DE; Bradbury I
BJOG; 2005 Jan; 112(1):80-3. PubMed ID: 15663402
[TBL] [Abstract][Full Text] [Related]
18. First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency.
Bestwick JP; Huttly WJ; Wald NJ
J Med Screen; 2008; 15(4):204-6. PubMed ID: 19106261
[TBL] [Abstract][Full Text] [Related]
19. Practical strategies in contingent sequential screening for Down syndrome.
Benn P; Wright D; Cuckle H
Prenat Diagn; 2005 Aug; 25(8):645-52. PubMed ID: 16049988
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies.
Spencer K; Aitken D
Ultrasound Obstet Gynecol; 2004 Dec; 24(7):735-9. PubMed ID: 15505874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
